SETT ATT FRAMSTELLA 1,3,4-TRIMETYL-2-(3,4,5-TRIMETOXIBENSYL)-1,2,5,6-TETRAHYDROPYRIDIN

A process for the preparation of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -1,2,5,6-tetrahydropyridine of the formula (I) ** (see formula) ** And its salts by addition of pharmaceutically acceptable acids, for example the hydrohates, characterized in that in a first stage of synthesis the 3,4,5-tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ROLADAN C M, JARQUE R G, PEINADO F R, CABIRO J C, CARTES J B
Format: Patent
Sprache:swe
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ROLADAN C M
JARQUE R G
PEINADO F R
CABIRO J C
CARTES J B
description A process for the preparation of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -1,2,5,6-tetrahydropyridine of the formula (I) ** (see formula) ** And its salts by addition of pharmaceutically acceptable acids, for example the hydrohates, characterized in that in a first stage of synthesis the 3,4,5-trimethoxybenzaldehyde of the formula is reacted ** (see formula) ** With the 2-bromo-3,4-dimethylpyridine of the formula: ** (see formula) ** Said reaction being carried out in solution in an inert solvent and in the presence of butyllithium at a reaction temperature comprised between -40ºC and room temperature, whereby 3,4,5-trimethoxyphenyl- is obtained as an intermediate product. (3,4-dimethyl-2-pyridyl) carbinol of the formula ii ** (see formula) ** Which in a second stage of synthesis is reacted at a temperature below 20ºC with thionyl chloride, and the chloride thus obtained dissolved in glacial acetic acid is reduced with zinc powder giving a product that treated with methyl iodide originates the iodide of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -pyridinium, which is treated with boron tetrahydride and sodium leads to the compound of formula i, which if desired is transformed into its salts of addition with pharmaceutically acceptable acids, for example the halohydrates. (Machine-translation by Google Translate, not legally binding)
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SE7505051LL</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SE7505051LL</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SE7505051LL3</originalsourceid><addsrcrecordid>eNrjZAgLdg0JUXAEYrcgR9_gEFcfH0cFQx1jHRPdkCBPX9eQSB9dI10NIF_HFCriH-Hp5OoXHOmjqWuoY6RjqmOmG-IaEuToEekS5B8QGeTp4unHw8CalphTnMoLpbkZFNxcQ5w9dFML8uNTiwsSk1PzUkvig13NTQ2A0NDHx5gIJQCoyi-R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SETT ATT FRAMSTELLA 1,3,4-TRIMETYL-2-(3,4,5-TRIMETOXIBENSYL)-1,2,5,6-TETRAHYDROPYRIDIN</title><source>esp@cenet</source><creator>ROLADAN C M ; JARQUE R G ; PEINADO F R ; CABIRO J C ; CARTES J B</creator><creatorcontrib>ROLADAN C M ; JARQUE R G ; PEINADO F R ; CABIRO J C ; CARTES J B</creatorcontrib><description>A process for the preparation of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -1,2,5,6-tetrahydropyridine of the formula (I) ** (see formula) ** And its salts by addition of pharmaceutically acceptable acids, for example the hydrohates, characterized in that in a first stage of synthesis the 3,4,5-trimethoxybenzaldehyde of the formula is reacted ** (see formula) ** With the 2-bromo-3,4-dimethylpyridine of the formula: ** (see formula) ** Said reaction being carried out in solution in an inert solvent and in the presence of butyllithium at a reaction temperature comprised between -40ºC and room temperature, whereby 3,4,5-trimethoxyphenyl- is obtained as an intermediate product. (3,4-dimethyl-2-pyridyl) carbinol of the formula ii ** (see formula) ** Which in a second stage of synthesis is reacted at a temperature below 20ºC with thionyl chloride, and the chloride thus obtained dissolved in glacial acetic acid is reduced with zinc powder giving a product that treated with methyl iodide originates the iodide of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -pyridinium, which is treated with boron tetrahydride and sodium leads to the compound of formula i, which if desired is transformed into its salts of addition with pharmaceutically acceptable acids, for example the halohydrates. (Machine-translation by Google Translate, not legally binding)</description><language>swe</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1975</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19751105&amp;DB=EPODOC&amp;CC=SE&amp;NR=7505051L$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19751105&amp;DB=EPODOC&amp;CC=SE&amp;NR=7505051L$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROLADAN C M</creatorcontrib><creatorcontrib>JARQUE R G</creatorcontrib><creatorcontrib>PEINADO F R</creatorcontrib><creatorcontrib>CABIRO J C</creatorcontrib><creatorcontrib>CARTES J B</creatorcontrib><title>SETT ATT FRAMSTELLA 1,3,4-TRIMETYL-2-(3,4,5-TRIMETOXIBENSYL)-1,2,5,6-TETRAHYDROPYRIDIN</title><description>A process for the preparation of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -1,2,5,6-tetrahydropyridine of the formula (I) ** (see formula) ** And its salts by addition of pharmaceutically acceptable acids, for example the hydrohates, characterized in that in a first stage of synthesis the 3,4,5-trimethoxybenzaldehyde of the formula is reacted ** (see formula) ** With the 2-bromo-3,4-dimethylpyridine of the formula: ** (see formula) ** Said reaction being carried out in solution in an inert solvent and in the presence of butyllithium at a reaction temperature comprised between -40ºC and room temperature, whereby 3,4,5-trimethoxyphenyl- is obtained as an intermediate product. (3,4-dimethyl-2-pyridyl) carbinol of the formula ii ** (see formula) ** Which in a second stage of synthesis is reacted at a temperature below 20ºC with thionyl chloride, and the chloride thus obtained dissolved in glacial acetic acid is reduced with zinc powder giving a product that treated with methyl iodide originates the iodide of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -pyridinium, which is treated with boron tetrahydride and sodium leads to the compound of formula i, which if desired is transformed into its salts of addition with pharmaceutically acceptable acids, for example the halohydrates. (Machine-translation by Google Translate, not legally binding)</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1975</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAgLdg0JUXAEYrcgR9_gEFcfH0cFQx1jHRPdkCBPX9eQSB9dI10NIF_HFCriH-Hp5OoXHOmjqWuoY6RjqmOmG-IaEuToEekS5B8QGeTp4unHw8CalphTnMoLpbkZFNxcQ5w9dFML8uNTiwsSk1PzUkvig13NTQ2A0NDHx5gIJQCoyi-R</recordid><startdate>19751105</startdate><enddate>19751105</enddate><creator>ROLADAN C M</creator><creator>JARQUE R G</creator><creator>PEINADO F R</creator><creator>CABIRO J C</creator><creator>CARTES J B</creator><scope>EVB</scope></search><sort><creationdate>19751105</creationdate><title>SETT ATT FRAMSTELLA 1,3,4-TRIMETYL-2-(3,4,5-TRIMETOXIBENSYL)-1,2,5,6-TETRAHYDROPYRIDIN</title><author>ROLADAN C M ; JARQUE R G ; PEINADO F R ; CABIRO J C ; CARTES J B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SE7505051LL3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>swe</language><creationdate>1975</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ROLADAN C M</creatorcontrib><creatorcontrib>JARQUE R G</creatorcontrib><creatorcontrib>PEINADO F R</creatorcontrib><creatorcontrib>CABIRO J C</creatorcontrib><creatorcontrib>CARTES J B</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROLADAN C M</au><au>JARQUE R G</au><au>PEINADO F R</au><au>CABIRO J C</au><au>CARTES J B</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SETT ATT FRAMSTELLA 1,3,4-TRIMETYL-2-(3,4,5-TRIMETOXIBENSYL)-1,2,5,6-TETRAHYDROPYRIDIN</title><date>1975-11-05</date><risdate>1975</risdate><abstract>A process for the preparation of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -1,2,5,6-tetrahydropyridine of the formula (I) ** (see formula) ** And its salts by addition of pharmaceutically acceptable acids, for example the hydrohates, characterized in that in a first stage of synthesis the 3,4,5-trimethoxybenzaldehyde of the formula is reacted ** (see formula) ** With the 2-bromo-3,4-dimethylpyridine of the formula: ** (see formula) ** Said reaction being carried out in solution in an inert solvent and in the presence of butyllithium at a reaction temperature comprised between -40ºC and room temperature, whereby 3,4,5-trimethoxyphenyl- is obtained as an intermediate product. (3,4-dimethyl-2-pyridyl) carbinol of the formula ii ** (see formula) ** Which in a second stage of synthesis is reacted at a temperature below 20ºC with thionyl chloride, and the chloride thus obtained dissolved in glacial acetic acid is reduced with zinc powder giving a product that treated with methyl iodide originates the iodide of 1,3,4-trimethyl-2- (3,4,5-trimethoxybenzyl) -pyridinium, which is treated with boron tetrahydride and sodium leads to the compound of formula i, which if desired is transformed into its salts of addition with pharmaceutically acceptable acids, for example the halohydrates. (Machine-translation by Google Translate, not legally binding)</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language swe
recordid cdi_epo_espacenet_SE7505051LL
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SETT ATT FRAMSTELLA 1,3,4-TRIMETYL-2-(3,4,5-TRIMETOXIBENSYL)-1,2,5,6-TETRAHYDROPYRIDIN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T20%3A25%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROLADAN%20C%20M&rft.date=1975-11-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESE7505051LL%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true